|
|
Office Locations:
|
2051 Ringwood Ave.
San Jose, CA 95131
Phone: 408-457-3700
Fax: 408-433-5440
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
InCube Ventures is a life science venture capital firm founded in 2008 and focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. The fund is built around Mir Imran, one of the leading healthcare innovators. InCube Ventures is managed by InCube Labs (see profile), a multi-disciplinary research lab that has been a highly productive source of medical device companies. Mir and InCube Labs have formed 20 companies over the past 25 years, creating a series of multi-billion dollar markets along the way. The fund's current portfolio includes companies that are developing novel treatment approaches in clinical areas such as atrial fibrillation, epilepsy, gastro intestinal surgery, iron-deficiency anemia, hemorrhagic stroke and metabolic disorders. InCube Ventures has returned $2 billion to its investors. 17 companies have been exited.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
